3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
5
Stomatitis
3
Head and Neck Neoplasms
3
Fatigue
3
Colorectal Neoplasms
3
Pain
2
Multiple Myeloma
2
Lung Neoplasms
2
Carcinoma, Hepatocellular
2
Ulcer
1
Trauma, Nervous System
1
Spondylitis, Ankylosing
1
Skin Neoplasms
1
Schwannomatosis
1
Rectal Neoplasms
1
Psoriasis
1
Pleural Effusion, Malignant
1
Pancreatic Cyst
1
Ovarian Neoplasms
1
Non-functioning Pituitary Adenoma
1
Neurofibromatosis 1
1
Neurilemmoma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Metastatic Non-Squamous Non-Small Cell Lung Cancer
1
Mesothelioma
1
Malignant Neoplasm of Colorectum
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma
1
Interventions
Water
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Serum Albumin, Human
1
Saline Solution
1
Neomycin
1
Metronidazole
1
Esophagectomy
1
Ciprofloxacin
1
Bioseal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Anastomotic Leak
×
Saline Solution
×
Clear all
NCT02682485
2023-04-26
SES-DTA
University of Chicago
Phase 2
Withdrawn